View More Recent Stories

Jul 11, 2018 04:30PM Clearside Biomedical Appoints Carol Hoang as Vice President, Medical Affairs
Jul 11, 2018 04:30PM Clearside Biomedical Appoints Carol Hoang as Vice President, Medical Affairs
Jun 13, 2018 04:32PM Clearside Biomedical (CLSD) Reports Complete Patient Enrollment in First of Two Phase 3 Clinical Trials of CLS-TA in Retinal Vein Occlusion
Jun 13, 2018 04:30PM Clearside Biomedical Announces Completion of Patient Enrollment in First of Two Phase 3 Clinical Trials of CLS-TA in Retinal Vein Occlusion
Jun 13, 2018 04:30PM Clearside Biomedical Announces Completion of Patient Enrollment in First of Two Phase 3 Clinical Trials of CLS-TA in Retinal Vein Occlusion
Jun 11, 2018 05:00PM Clearside Biomedical to Participate in 2018 JMP Securities Life Sciences Conference
Jun 11, 2018 05:00PM Clearside Biomedical to Participate in 2018 JMP Securities Life Sciences Conference
May 31, 2018 07:32AM Clearside Biomedical (CLSD) Reports Positive Topline Results from Phase 2 Clinical Trial of CLS-TA Used with Eylea in Patients with Diabetic Macular Edema
May 31, 2018 07:30AM Clearside Biomedical Announces Positive Topline Results from Phase 2 Clinical Trial of CLS-TA Used with Eylea in Patients with Diabetic Macular Edema
May 31, 2018 07:30AM Clearside Biomedical Announces Positive Topline Results from Phase 2 Clinical Trial of CLS-TA Used with Eylea in Patients with Diabetic Macular Edema
Jun 8, 2016 10:00AM Clearside Biomedical, Inc. (Nasdaq: CLSD) to Ring The Nasdaq Stock Market Closing Bell
View More Recent Stories